Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Palatka › NPI 1487045100
Hospital

Putnam Community Medical Center of North Florida, LLC

Putnam Community Medical Center of North Florida, LLC was paid $22.35M by Medicaid between Jan 2018 and Dec 2024, across 169 billing codes. Its largest line is 99283, emergency room visit (moderate) — 31% of everything it billed.

33Billing provider infoPUTNAM COMMUNITY MEDICAL CENTER OF NORTH FLORIDA, LLC
PALATKA, FL 32177
33aNPI1487045100assigned 02/17/2015
33bProvider typeGeneral Acute Care Hospital
28Total paid$22.35M
24GClaims492,386
24DCodes billed169
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Florida

Rank by total paid#11 of 163
Median peer was paid$4.77M
This provider vs. median4.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201866,512$747K
2019109,372$4.44M
202078,839$3.14M
202178,303$4.06M
202274,385$4.39M
202353,174$3.59M
2024incomplete31,801$1.98M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 31% 54,509 48,295 $6.86M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 12% 25,674 21,297 $2.60M
97530 Therapeutic activities, direct patient contact, each 15 minutes 7.9% 15,055 4,480 $1.76M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 7.7% 10,917 2,842 $1.71M
74176 Computed tomography, abdomen and pelvis; without contrast material 5.7% 5,893 5,035 $1.28M
99282 Emergency department visit for the evaluation and management, low to moderate severity 4.2% 6,720 6,274 $935K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 4.0% 9,731 2,801 $903K
70450 Computed tomography, head or brain; without contrast material 3.8% 5,387 4,264 $856K
80053 Comprehensive metabolic panel 2.9% 21,013 16,807 $644K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 2.4% 4,779 3,878 $528K
96361 Intravenous infusion, hydration; each additional hour 2.2% 2,429 2,049 $483K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1.8% 2,340 2,217 $404K
157 more codes
36415 Collection of venous blood by venipuncture 1.7% 10,728 $379K
80048 Basic metabolic panel (calcium, ionized) 1.4% 8,622 $315K
87070 <1% 8,078 $179K
80047 <1% 1,838 $112K
92523 <1% 586 $109K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 634 $107K
85027 <1% 31,550 $106K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 4,612 $97K
81001 <1% 14,350 $91K
A9270 Non-covered item or service <1% 6,400 $87K
71045 Radiologic examination, chest; single view <1% 13,889 $82K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 1,249 $76K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 402 $73K
71046 Radiologic examination, chest; 2 views <1% 2,630 $51K
71250 <1% 735 $48K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 6,352 $47K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 13,776 $46K
84484 <1% 9,847 $46K
97163 <1% 624 $44K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 589 $42K
97167 <1% 248 $41K
73610 <1% 919 $41K
73630 <1% 1,292 $37K
85610 <1% 6,563 $34K
73130 <1% 817 $34K
G0378 Hospital observation service, per hour <1% 1,995 $33K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 14,262 $33K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 516 $33K
72125 Computed tomography, cervical spine; without contrast material <1% 1,393 $32K
85730 <1% 5,788 $30K
81025 <1% 8,643 $30K
10060 <1% 203 $27K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 812 $26K
83735 <1% 8,380 $26K
J2704 Injection, propofol, 10 mg <1% 825 $25K
J7030 Infusion, normal saline solution , 1000 cc <1% 8,563 $25K
84702 <1% 853 $25K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 4,510 $25K
12001 <1% 228 $24K
73030 <1% 785 $23K
71275 Computed tomographic angiography, chest, with contrast material <1% 42 $22K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 572 $21K
84443 Thyroid stimulating hormone (TSH) <1% 3,088 $20K
87077 <1% 2,076 $20K
83880 <1% 5,214 $20K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 45 $20K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 6,140 $19K
81003 <1% 2,792 $18K
87088 <1% 3,819 $18K
73110 <1% 415 $17K
59025 Fetal non-stress test <1% 383 $16K
74018 <1% 585 $16K
73562 <1% 623 $16K
87275 <1% 2,490 $16K
80076 <1% 2,758 $13K
72100 <1% 544 $13K
83690 <1% 6,700 $13K
96375 Therapeutic injection; each additional sequential IV push <1% 7,109 $13K
83605 <1% 2,555 $13K
87040 <1% 2,235 $13K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 5,006 $12K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 644 $12K
J7120 Ringers lactate infusion, up to 1000 cc <1% 550 $12K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 7,882 $12K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 446 $11K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 8,231 $11K
97162 <1% 148 $11K
77067 Screening mammography, bilateral, including computer-aided detection <1% 363 $11K
J7999 Compounded drug, not otherwise classified <1% 1,233 $10K
86900 <1% 804 $9K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 843 $9K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 152 $9K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 5,472 $9K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 790 $9K
80061 Lipid panel <1% 3,136 $8K
73140 <1% 110 $8K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,925 $8K
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,154 $7K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,995 $6K
76801 <1% 211 $6K
72131 <1% 92 $6K
83036 Hemoglobin; glycosylated (A1C) <1% 2,502 $6K
86850 <1% 322 $6K
70486 <1% 76 $6K
86901 <1% 781 $5K
J2060 Injection, lorazepam, 2 mg <1% 1,133 $5K
G1003 Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program <1% 286 $4K
93971 <1% 211 $4K
12011 <1% 40 $4K
87186 <1% 1,858 $4K
82248 <1% 1,046 $4K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 48 $4K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 809 $3K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 196 $3K
87086 Culture, bacterial; quantitative colony count, urine <1% 1,498 $3K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,424 $3K
87807 <1% 1,843 $3K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 1,674 $3K
82550 <1% 776 $3K
J1170 Injection, hydromorphone, up to 4 mg <1% 834 $3K
12002 <1% 26 $2K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 13 $2K
J1815 Injection, insulin, per 5 units <1% 241 $2K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 93 $2K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 148 $2K
93976 <1% 64 $2K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,423 $2K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 43 $2K
85379 <1% 667 $2K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 1,130 $1K
J1644 Injection, heparin sodium, per 1000 units <1% 57 $1K
84439 <1% 791 $1K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 12 $1K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 824 $1K
76770 <1% 14 $1K
87205 <1% 235 $1K
96376 <1% 641 $940.60
73090 <1% 14 $903.01
73080 <1% 26 $854.17
82077 <1% 650 $800.26
73502 <1% 73 $786.19
87210 <1% 104 $718.70
J0360 Injection, hydralazine hcl, up to 20 mg <1% 176 $717.78
86140 <1% 558 $592.07
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 175 $475.44
82043 <1% 160 $344.31
85652 <1% 167 $324.19
84100 <1% 83 $323.07
82009 <1% 31 $244.10
84550 <1% 86 $238.07
82607 <1% 182 $204.23
80164 <1% 13 $178.64
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 29 $133.68
90715 <1% 31 $109.41
84436 <1% 141 $99.57
87400 <1% 1,241 $69.01
82746 <1% 17 $65.65
82570 <1% 33 $47.24
80329 <1% 51 $37.74
87430 <1% 934 $31.56
82272 <1% 35 $25.75
J2550 Injection, promethazine hcl, up to 50 mg <1% 29 $14.90
80320 <1% 338 $11.49
J3475 Injection, magnesium sulfate, per 500 mg <1% 15 $0.61
73564 0% 30 $0.00
83050 0% 17 $0.00
J0561 Injection, penicillin g benzathine, 100,000 units 0% 27 $0.00
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 0% 14 $0.00
82553 0% 45 $0.00
90714 0% 29 $0.00
82140 0% 14 $0.00
87420 0% 52 $0.00
36600 0% 17 $0.00
J1650 Injection, enoxaparin sodium, 10 mg 0% 21 $0.00
82375 0% 17 $0.00
83540 0% 13 $0.00
00731 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPRUITT, PHILIP (CFO)